HLA and alopecia areata in Jerusalem

Area of Science:

• Immunogenetics
• Dermatology
• Human genetics

Background:

• Alopecia areata (AA) is an autoimmune condition causing hair loss.
• Genetic factors are implicated in the pathogenesis of AA.
• Human Leukocyte Antigen (HLA) genes are crucial in immune responses and have been associated with various autoimmune diseases.

Purpose of the Study:

• To investigate the association between specific Human Leukocyte Antigen (HLA) alleles and the prevalence of Alopecia areata (AA).
• To determine if the Human Leukocyte Antigen B18 (HLA-B18) allele is more frequent in patients with AA compared to a control group.

Main Methods:

• A case-control study was conducted involving 46 patients diagnosed with Alopecia areata (AA).
• A control group was used for comparison of allele frequencies.
• Human Leukocyte Antigen (HLA) typing was performed on all participants.

Main Results:

• The frequency of the HLA-B18 allele was significantly higher in the Alopecia areata (AA) patient group (23.9%) compared to the control population (7.4%).
• This finding corresponds to a relative risk of 3.9% for developing AA in individuals with the HLA-B18 allele.
• The observed association between HLA-B18 and AA was consistent across different patient origins, sexes, ages of onset, and types of alopecia areata.

Conclusions:

• The Human Leukocyte Antigen B18 (HLA-B18) allele is significantly associated with Alopecia areata (AA).
• This genetic marker may contribute to the susceptibility of developing Alopecia areata (AA).
• Further research into the immunogenetic mechanisms underlying this association is warranted.